Patient info Open main menu

Perindopril Arginine/indapamide Krka 5 mg/1.25 mg tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine strength:
5 mg/1.25 mg
Contains active substances:

Patient leaflet - Perindopril Arginine/indapamide Krka 5 mg/1.25 mg tablets

1. What Perindopril arginine/indapamide Krka is and what it is used for

What are Perindopril arginine/indapamide Krka tablets?

Perindopril arginine/indapamide Krka is a combination of two active ingredients, perindopril and indapamide. Perindopril arginine/indapamide Krka is an

anti

‑

hypertensive and is used in the treatment of high blood pressure (hypertension) in adults.

What Perindopril arginine/indapamide Krka tablets are used for?

Perindopril belongs to a class of medicines called angiotensin-converting enzyme inhibitors (ACE inhibitors). These work by widening the blood vessels, which makes it easier for your heart to pump blood through them. Indapamide is a diuretic. Diuretics increase the amount of urine produced by the kidneys. However, indapamide is different from other diuretics, as it only causes a slight increase in the amount of urine produced. Each of the active ingredients reduces blood pressure and they work together to control your blood pressure.

2. What you need to know before you take Perindopril arginine/indapamide Krka

Do not take Perindopril arginine/indapamide Krka

  • if you are allergic to perindopril or any other ACE inhibitor; or to indapamide or any other sulphonamides or any of the other ingredients of this medicine (listed in section 6),
  • if you have experienced symptoms such as wheezing, swelling of the face or tongue, intense itching or severe skin rashes with previous ACE inhibitor treatment or if you or a member of your family have had these

    symptoms in any other circumstances (a condition called angioedema),

    • if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren,
    • if you have severe liver disease or suffer from a condition called hepatic encephalopathy (a degenerative disease of the brain),
    • if you have a severe kidney disease where the blood supply to your kidneys is reduced (renal artery stenosis),
    • if you have severe renal impairment (creatinine clearance below 30 ml/min),
    • if you are receiving dialysis, or any other type of blood filtration. Depending on the machine that is used, Perindopril arginine/indapamide Krka may not be suitable for you,
    • if you have low blood potassium,
    • if you are suspected of having untreated decompensated heart failure (symptoms can include severe water retention, difficulty in breathing),
    • if you are more than 3 months pregnant. (It is also better to avoid Perindopril arginine/indapamide Krka in early pregnancy – see pregnancy section.),
    • if you have taken or are currently taking sacubitril/ valsartan, a medicine for heart failure, as the risk of angioedema (rapid swelling under the skin in an area such as the throat) is increased (see “Warning and Precaution” and “Other medicines and Perindopril arginine/indapamide Krka”).

Warnings and precautions

Talk to your doctor or pharmacist before taking Perindopril arginine/indapamide Krka:

  • if you have aortic stenosis (narrowing of the main blood vessel leading from the heart) or hypertrophic cardiomyopathy (heart muscle disease) or renal artery

    stenosis (narrowing of the artery supplying the kidney with blood),

    • if you have heart failure or any other heart problems,
    • if you have kidney problems, or if you are receiving dialysis,
    • if you experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to weeks of taking Perindopril arginine/indapamide Krka. This can lead to permanent vision loss, if not treated. If you earlier have had a penicillin or sulfonamide allergy, you can be at higher risk of developing this,
    • if you have muscle disorders including muscle pain, tenderness, weakness or cramps,
    • if you have abnormally increased levels of a hormone called aldosterone in your blood (primary aldosteronism),
    • if you have liver problems,
    • if you suffer from a collagen disease (skin disease) such as systemic lupus erythematosus or scleroderma,
    • if you have atherosclerosis (hardening of the arteries),
    • if you suffer from hyperparathyroidism (overactive parathyroid gland),
    • if you suffer from gout,
    • if you have diabetes,
    • if you are on a salt restricted diet or use salt substitutes which contain potassium,
    • if you take lithium or potassium-sparing drugs (spironolactone, triamterene) or potassium supplements as their use with Perindopril arginine/indapamide Krka tablets should be avoided (see “Other medicines and Perindopril arginine/indapamide Krka”),
    • if you are elderly,
    • if you have had photosensitivity reactions,
    • if you have a severe allergic reaction with swelling of the face, lips, mouth, tongue or throat which may cause

      difficulty in swallowing or breathing (angioedema). This may occur at any time during treatment. If you develop such symptoms, you should stop taking the treatment and see a doctor immediately.

      • if you are taking any of the following medicines used to treat high blood pressure:

        • an angiotensin II receptor blocker (ARBs) (also known as sartans - for example valsartan, telmisartan, irbesartan), in particular if you have diabetes-related kidney problems.
        • aliskiren.

Your doctor may check your kidney function, blood pressure, and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.

See also information under the heading “Do not take Perindopril arginine/indapamide Krka”.

  • if you are of black origin since you may have a higher risk of angioedema and this medicine may be less effective in lowering your blood pressure than in non-black patients,
  • if you are a haemodialysis patient dialysed with high-flux membranes,
  • if you are taking any of the following medicines, the risk of angioedema is increased:

    • racecadotril (used to treat diarrhea),
    • sirolimus, everolimus, temsirolimus and other drugs belonging to the class of so-called mTor inhibitors (used to avoid rejection of transplanted organs and for cancer), - sacubitril (available as fixed-dose combination with valsartan), used to treat long-term heart failure, - linagliptin, saxagliptin, sitagliptin, vildagliptin and other drugs belonging to the class of the also called gliptins (used to treat diabetes).

Angioedema

Angioedema (a severe allergic reaction with swelling of the face, lips, tongue or throat with difficulty in swallowing or

breathing) has been reported in patients treated with ACE inhibitors, including Perindopril arginine/indapamide Krka. This may occur at any time during treatment. If you develop such symptoms, you should stop taking Perindopril arginine/indapamide Krka and see a doctor immediately. See also section 4.

You must tell your doctor if you think that you are (or might become) pregnant. Perindopril arginine/indapamide Krka is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see “Pregnancy and breast-feeding”).

When you are taking Perindopril arginine/indapamide Krka tablets, you should also inform your doctor or the medical staff:

  • if you experience dry cough,
  • if you are to undergo anaesthesia and/or surgery,
  • if you have recently suffered from diarrhoea or vomiting, or are dehydrated,
  • if you are to undergo dialysis or LDL apheresis (which is removal of cholesterol from your blood by a machine),
  • if you are going to have desensitisation treatment to reduce the effects of an allergy to bee or wasp stings,
  • if you are to undergo a medical test that requires injection of an iodinated contrast agent (a substance that makes organs like kidney or stomach visible on an X-ray),
  • if you have changes in your vision or pain in one or both of your eyes while taking Perindopril arginine/indapamide Krka. This could be a sign that you are developing glaucoma, increased pressure in your eye(s). You should discontinue Perindopril arginine/indapamide Krka treatment and seek medical attention.

Athletes should be aware that Perindopril arginine/ indapamide Krka tablets contain an active ingredient (indapamide), which may give a positive reaction in drug tests.

Children and adolescents

Perindopril arginine/indapamide Krka tablets should not be given to children and adolescents.

Other medicines and Perindopril arginine/indapamide Krka

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. You should avoid taking Perindopril arginine/indapamide Krka tablets with:

  • lithium (used to treat mania or depression),
  • aliskiren (medicine used to treat hypertension) if you have no diabetes mellitus or kidney problems,
  • potassium-sparing diuretics (e.g. triamterene, amiloride), potassium salts other drugs which can increase potassium in your body (such as heparin, a medicine used to thin blood to prevent clots; trimethoprim and co

    ‑

    trimoxazole also known as trimethoprim/ sulfamethoxazole for infections caused by bacteria),

  • estramustine (used in cancer therapy),
  • other medicines used to treat high blood pressure: angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers.

Treatment with Perindopril arginine/indapamide Krka can be affected by other medicines. Your doctor may need to change your dose and/or to take other precautions. Make sure to tell your doctor if you are taking any of the following medicines as special care may be required:

  • other medicines for treating high blood pressure, including angiotensin II receptor blocker (ARB) or aliskiren (see also information under the headings “Do not take Perindopril arginine/indapamide Krka” and “Warnings and precautions”) or diuretics (medicines which increase the amount of urine produced by the kidneys),

    • potassium-sparing drugs used in the treatment of heart failure: eplerenone and spironolactone at doses between 12.5 mg to 50 mg per day,
    • medicines, which are most often used to treat diarrhea (racecadotril) or avoid rejection of transplanted organs (sirolimus, everolimus, temsirolimus and other drugs belonging to the class of so-called mTor inhibitors). See section “Warnings and precautions”,
    • sacubitril/valsartan (used to treat long-term heart failure). See sections “Do not take Perindopril arginine/ indapamide Krka” and “Warnings and precautions”,
    • anaesthetic medicines,
    • iodinated contrast agent,
    • antibiotics used to treat bacterial infections (e.g moxifloxacin, sparfloxacin, erythromycin by injection),
    • methadone (used to treat addiction),
    • procainamide (for the treatment of an irregular heart beat),
    • medicines for cancer (cytostatics),
    • allopurinol (for the treatment of gout),
    • antihistamines used to treat allergic reactions, such as hay fever (e.g mizolastine, terfenadine or astemizole,
    • corticosteroids used to treat various conditions including severe asthma and rheumatoid arthritis,
    • immunosuppressants used for the treatment of auto-immune disorders or following transplant surgery to prevent rejection (e.g. ciclosporin, tacrolimus),
    • halofantrine (used to treat certain types of malaria),
    • pentamidine (used to treat pneumonia),
    • injectable gold (used to treat rheumatoid polyarthritis),
    • vincamine (used to treat symptomatic cognitive disorders in elderly including memory loss),
    • bepridil (used to treat angina pectoris),
    • medicines used for heart rhythm problems (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, ibutilide, dofetilide, digitalis, bretylium),

MockUp028553_2

CONFIDENTIAL

1111111

iKRKk I'll"

smer branja kode/direction of reading PhC smer branja kode/direction of reading PhC smer vlaken/direction on fibre

130 mm ± 0,5 mm xx PL. Perindopril arginine/indapamide Krka 5 mg/1.25 mg tablets GB

second page

  • cisapride, diphemanil (used to treat gastric and digestive problems),
  • digoxin or other cardiac glycosides (for the treatment of heart problems),
  • baclofen (to treat muscle stiffness occurring in diseases such as multiple sclerosis),
  • medicines to treat diabetes such as insulin, metformin or gliptins,
  • calcium including calcium supplements,
  • stimulant laxatives (e.g. senna),
  • non-steroidal anti-inflammatory drugs (e.g. ibuprofen) or high dose salicylates (e.g. acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever, as well as to prevent blood clotting),
  • amphotericin B by injection (to treat severe fungal disease),
  • medicines used to treat mental disorders such as depression, anxiety, schizophrenia…(e.g. tricyclic antidepressants, neuroleptics (such as amisulpride, sulpiride, sultopride, tiapride, haloperidol, droperidol)),
  • tetracosactide (to treat Crohn’s disease),
  • trimethoprim (for the treatment of infections),
  • vasodilators including nitrates (products that make the blood vessels become wider),
  • medicines used for the treatment of low blood pressure, shock or asthma (e.g. ephedrine, noradrenaline or adrenaline).

Perindopril arginine/indapamide Krka with food and drink

It is preferable to take Perindopril arginine/indapamide Krka tablets before a meal.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Perindopril arginine/indapamide Krka before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Perindopril arginine/indapamide Krka. Perindopril arginine/indapamide Krka is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy. Breast-feeding

Perindopril arginine/indapamide Krka is not recommended for mothers who are breast

‑

feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is

newborn, or was born prematurely.

See your doctor immediately.

Driving and using machines

Perindopril arginine/indapamide Krka tablets usually does not affect alertness but different reactions such as dizziness or weakness in relation to the decrease in blood pressure may occur in certain patients. If affected, your ability to drive or to operate machinery may be impaired. Perindopril arginine/indapamide Krka contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Perindopril arginine/ indapamide Krka

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose of Perindopril arginine/ indapamide Krka 5 mg/1.25 mg tablets is one tablet once a day.

Your doctor may decide to modify the dosage regimen if you suffer from renal impairment.

It is preferable to take your tablet in the morning and before a meal.

Swallow the tablet with a glass of water.

Perindopril arginine/indapamide Krka 5 mg/1.25 mg tablets The tablet can be divided into equal doses.

If you take more Perindopril arginine/indapamide Krka than you should

If you take too many tablets, contact your doctor or nearest hospital casualty immediately. The most likely effect in case of overdose is low blood pressure.

If marked low blood pressure occurs (associated with nausea, vomiting, cramps, dizziness, sleepiness, mental confusion, changes in the amount of urine produced by kidneys), lying down with the legs raised can help. If you forget to take Perindopril arginine/indapamide Krka

It is important to take your medicine every day as regular treatment is more effective. However, if you forget to take a dose of Perindopril arginine/indapamide Krka tablets, take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

If you stop taking Perindopril arginine/indapamide Krka

As the treatment for high blood pressure is usually life-long, you should discuss with your doctor before stopping this medicinal product.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking the medicinal product and see a doctor immediately, if you experience any of the following, side effects that can be serious.

  • Severe dizziness or fainting due to low blood pressure (Common - may affect up to 1 in 10 people),
  • Bronchospasm (tightening of the chest, wheezing and shortness of breath (Uncommon - may affect up to 1 in 100 people),
  • Swelling of the face, lips, mouth, tongue or throat, difficulty in breathing (angioedema) (See section 2 “Warning and precaution”) (Uncommon - may affect up to 1 in 100 people),
  • Severe skin reactions including erythema multiforme (a skin rash which often starts with red itchy patches on your face, arms or legs) or intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome, toxic epidermal necrolysis) or other allergic reactions (Very rare - may affect up to 1 in 10,000 people),
  • Cardiovascular disorders (irregular heart beat, angina pectoris (pains to the chest, jaw and back, brought on by physical effort), heart attack) (Very rare - may affect up to 1 in 10,000 people),
  • Weakness of arms or legs, or problems speaking which could be a sign of a possible stroke (Very rare - may affect up to 1 in 10,000 people),
  • Inflamed pancreas which may cause severe abdominal and back pain accompanied with feeling very unwell (Very rare - may affect up to 1 in 10,000 people),

    • Yellowing of the skin or eyes (jaundice) which could be a sign of hepatitis (Very Rare - may affect up to 1 in 10,000 people),
    • Life-threatening irregular beat.(Not known),
    • Disease of the brain caused by liver illness (Hepatic encephalopathy) (Not known),
    • Muscle weakness, cramps, tenderness or pain and particularly, if at the same time, you feel unwell or have a high temperature it may be caused by an abnormal muscle breakdown (Not known).

In decreasing order of frequency, side effects can include: Common (may affect up to 1 in 10 people):

  • skin reactions in subjects predisposed to allergic and asthmatic reactions, headache, dizziness, vertigo, pins and needles, vision disturbances, tinnitus (sensation of noises in the ears), cough, shortness of breath (dyspnoea), gastro-intestinal disorders (nausea, vomiting, abdominal pain, taste disturbances, dyspepsia or difficulty of digestion, diarrhoea, constipation), allergic reactions (such as skin rashes, itching), cramps, feeling of tiredness, low potassium in the blood.

Uncommon (may affect up to 1 in 100 people):

  • mood swings, sleep disturbances, depression, urticaria, purpura (red pinpoints on skin), blister cluster, kidney problems, impotence (inability to obtain or maintain an erection), sweating, an excess of eosinophils (a type of white blood cells), change in laboratory parameters: high blood level of potassium reversible on discontinuation, low blood level of sodium that may lead to dehydration and low blood pressure, somnolence, fainting, palpitations (awareness of your heartbeat), tachycardia (fast heartbeat), hypoglycaemia (very low blood sugar level) in case of diabetic patients, vasculitis (inflammation of blood vessels), dry mouth, photosensitivity reactions (increased sensitivity of the skin to sun), arthralgia (joint

    pain), myalgia (muscle pain), chest pain, malaise, oedema peripheral, fever, increased blood urea, increased blood creatinine, fall.

    Rare (may affect up to 1 in 1000 people):

    • psoriasis worsening, changes in laboratory parameters: increased level of liver enzymes, high level of serum bilirubin, fatigue, decreased or absent urine output, flushing, acute renal failure,
    • dark urine, feeling sick (nausea) or being sick (vomiting), muscle cramps, confusion and seizures. These may be symptoms of a condition called SIADH (inappropriate antidiuretic hormone secretion),
    • low chloride in the blood, low magnesium in the blood. Very rare (may affect up to 1 in 10,000 people):
    • confusion, eosinophilic pneumonia (a rare type of pneumonia), rhinitis (blocked up or runny nose), severe kidney problems, changes in blood values such as a lower number of white and red blood cells, lower haemoglobin, lower number of blood platelets, high level of calcium in the blood, abnormal hepatic function. Not known (frequency cannot be estimated from the available data):
    • abnormal ECG heart tracing, changes in laboratory parameters: high uric acid levels and high sugar levels in the blood, short sightedness (myopia), vision blurred, visual impairment, decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma), discoloration, numbness and pain in fingers or toes (Raynaud’s phenomenon).
    • If you suffer from systemic lupus erythematosus (a type of collagen disease), this might get worse.

Disorders of the blood, kidney, liver or pancreas and changes in laboratory parameters (blood tests) can occur. Your doctor may need to give you blood tests to monitor your condition.

If you have these symptoms contact your doctor as soon as possible.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Perindopril arginine/ indapamide Krka

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date refers to the last day of that month.

Store in the original package in order to protect from light. This medicine does not require any special temperature storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Perindopril arginine/indapamide Krka contains

  • The active substances are perindopril arginine and indapamide.

    Perindopril arginine/indapamide Krka 5 mg/1.25 mg tablets

    Each tablet contains 5 mg perindopril arginine (equivalent to 3.395 mg perindopril) and 1.25 mg indapamide.

    • The other ingredients are: calcium chloride hexahydrate, microcrystalline cellulose (E460), silicified microcrystalline cellulose (microcrystalline cellulose (E460) and colloidal anhydrous silica), pregelatinised starch, sodium hydrogen carbonate, colloidal hydrated silica and magnesium stearate (E470b).

See section 2 “Perindopril arginine/indapamide Krka contains sodium”.

What Perindopril arginine/indapamide Krka looks like and contents of the pack

Perindopril arginine/indapamide Krka 5 mg/1.25 mg tablets White or almost white, capsule-shaped tablet, scored on both sides. Tablet is engraved with mark A on one side of the score line and with mark 1 on the other side of the score line. Tablet dimensions: approx. 8 mm x 5 mm. The tablet can be divided into equal doses.

Perindopril arginine/indapamide Krka is available in blisters containing: 10, 30, 60, 90 and 100 tablets, in a box. Not all pack sizes may be marketed.

Marketing Authorisation Holder and manufacturer

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

This leaflet was last revised in 11/2025.

MockUp028553_2

CONFIDENTIAL

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 01656/0475

Last revision stated in the text: November 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Perindopril Arginine/indapamide Krka 5 mg/1.25 mg tablets

Active substances Indapamide, Perindopril arginine
Strength 5 mg/1.25 mg
Pharmaceutical form White or almost white, capsule-shaped tablet, scored on both sides. Tablet is engraved with mark A on one side of the score line and with mark 1 on the other side of the score line. Tablet dimensions: approx. 8 mm x 5 mm.
The tablet can be divided into equal doses.
Excipients Calcium chloride hexahydrate, Microcrystalline cellulose (E460), Silicified microcrystalline cellulose, Colloidal anhydrous silica, Pregelatinised starch, Sodium hydrogen carbonate, Colloidal hydrated silica, Magnesium stearate (E470b)
Shelf life 3 years
Storage Store in the original package in order to protect from light. This medicinal product does not require any special temperature storage conditions.
Drug group (ATC) Perindopril and diuretics
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09B ACE inhibitors, combinations
        1. C09BA ACE inhibitors and diuretics
          1. C09BA04 perindopril and diuretics
Marketing authorisation PL 01656/0475 (first authorised 7 January 2026)
Marketing authorisation holder KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.